News from therachon ag A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

17 May, 2019, 13:00 BST Therachon to Present Data from Ongoing Phase II Study of Apraglutide for Short Bowel Syndrome (SBS) at Digestive Disease Week

Therachon AG ("Therachon"), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative...


30 Jan, 2019, 13:00 GMT Therachon Strengthens Board of Directors with the Appointment of Industry Leaders Sandip Kapadia and Patrick Machado

Therachon AG ("Therachon"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of innovative...


16 Jan, 2019, 13:00 GMT Therachon is Granted Orphan Drug Designation by US FDA for Apraglutide for the Treatment of Short Bowel Syndrome

Therachon AG ("Therachon"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of innovative...


08 Jan, 2019, 13:00 GMT Therachon Appoints Claudia D'Augusta, Ph.D., as Chief Financial Officer

Therachon AG ("Therachon"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of innovative...


29 Nov, 2018, 13:30 GMT Therachon is granted Orphan Drug Designation in the European Union for Apraglutide for the Treatment of Short Bowel Syndrome

Therachon AG ("Therachon"), a clinical-stage biotechnology company focused on treating the root causes of rare conditions, today announced that the...


09 Oct, 2018, 08:00 BST Therachon Expands Rare Disease Pipeline with Acquisition of GLyPharma Therapeutic Inc.

Therachon AG ("Therachon"), a clinical-stage biotechnology company focused on treating root causes of rare conditions, today announced the...